Saturday 17 October 2026
Export NIVF’s income statement to Excel — free account
NewGenIvf Group Limited
NIVF Healthcare Medical Care Facilities
NewGenIvf Group Limited’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 13.0% from fiscal 2024. Dividend growth for five consecutive years; insiders bought in the last twelve months.
0.28
0.03
+12.00%
Follow NIVF
NewGenIvf Group Limited (NIVF) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CCM Concord Medical Services Holdings Limited compare | n/m |
| NVOS Novo Integrated Sciences, Inc. compare | n/m |
| CANOQ Cano Health, Inc. compare | n/m |
| AMS American Shared Hospital Services compare | n/m |
| MODVQ ModivCare Inc. compare | n/m |
| RHEP Adcare Health Systems Inc compare | 0.6× |
| SYRA Syra Health Corp. compare | 84.0× |
| NIVF NewGenIvf Group Limited | — |
| BMGL Basel Medical Group Ltd compare | — |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)